# Creon in HIV Patients With Steatorrhea

> **NCT00623025** · PHASE3 · TERMINATED · sponsor: **Abbott** · enrollment: 34 (actual)

## Conditions studied

- Steatorrhea

## Interventions

- **DRUG:** Creon 25000
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00623025
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-01
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 34 (ACTUAL)
- **Why stopped:** Discontinued prematurely due to low enrollment
- **Last updated:** 2011-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00623025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00623025, "Creon in HIV Patients With Steatorrhea". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00623025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*